Article Details

Exscientia announces first AI immuno-oncology drug to enter trials

Retrieved on: 2021-04-09 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

Exscientia announces first AI immuno-oncology drug to enter trials. View article details on hiswai:

Excerpt

Pre-clinical data related to the project will be presented at the American Association for Cancer Research (AACR) annual meeting, to be held from the ...

Article found on: www.information-age.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up